Results 111 to 120 of about 15,547 (188)

NAMD: A Case Study in Multilingual Parallel Programming

, 1997
. Parallel languages are tools for constructing efficient application programs, while reducing the required labor. In this light, using the most appropriate tool for each component of a complex system seems natural, resulting in multi-paradigm ...
R. Brunner, N. Krawetz, A. Shinozaki, J. Phillips, M. Bh, L.V. Kalé, M. Bhandarkar   +6 more
core  

VEGF Inhibition Associates With Decreased Risk of Mortality in Patients With Neovascular Age-related Macular Degeneration

Ophthalmology Science
Purpose: Controversy exists regarding the systemic safety of intravitreal VEGF inhibitors in the treatment of neovascular age-related macular degeneration (nAMD). We aimed to investigate the potential impact of VEGF inhibitor treatment on the risk of all-
Benjamin Sommer Thinggaard, MD, Katrine Frederiksen, MD, PhD, Yousif Subhi, MD, PhD, Sören Möller, PhD, Torben Lykke Sørensen, MD, DMSc, Ryo Kawasaki, MPH, PhD, Jakob Grauslund, MD, PhD, DMSc, Lonny Stokholm, PhD   +7 more
doaj   +1 more source

Faricimab in the Treatment of Exudative Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Italy: The FARIT Real World Study

Ophthalmology and Therapy
Introduction Faricimab is a bispecific antibody that enables greater disease control and extended durability compared with vascular endothelial growth factor (VEGF) inhibition alone in neovascular age-related macular degeneration (nAMD) and diabetic ...
Marco Lupidi, Cristiana Iaculli, Luisa Marco, Settimio Rossi, Emilia Sicari, Giulia Villa, Vittorio Pirani   +6 more
doaj   +1 more source

Real-world performance of faricimab for neovascular age-related macular degeneration and diabetic macular edema: experience from the BrazilRetNet multicenter study. Report 1

International Journal of Retina and Vitreous
Background To investigate real-world use of faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).
Vinicius Kniggendorf, Thiago C. Silveira, Vitor D. M. Costa, Danilo S. Soriano, Caio V. Regatieri, Renata F. Sugai, Arnaldo Bordon, Giovanna S. Nutels, Ana L. Peixoto, Carlos Augusto Moreira-Neto, Joao Victor C. Miranda, Marcio B. Nehemy, Francisco M. Damico, Leandro C. Zacharias, Daniel Lavinsky, Cleide G. Machado, Carlos Eduardo D. Veloso, Francyne V. Cyrino, Wener Cella, Luiz Roisman, Oswaldo F. Brasil, Gabriel C. Andrade, Francisco Stefanini, Fernando K. Malerbi, Fernando M. Penha, BrazilRetNet, Brazilian Retinal Research Network   +25 more
doaj   +1 more source

NAMD Benchmarking on Publicly Available Philippine Computational Resources

, 2017
NAMD benchmarks were done on five different proteins with varying system sizes (anoplin, kalata B1, North-Atlantic ocean pout antifreeze protein, Pseudomonas aeruginosa PAO1 lipase and octopamine receptor in mushroom bodies, OAMB) solvated with TIP3P ...
dela Cruz, Ren Tristan; Department of Computer Science University of the Philippines Diliman Quezon City Philippines 1101, Claudio, Gil; Institute of Chemistry University of the Philippines Diliman Quezon City Philippines 1101, Nellas, Ricky Bendanillo; Institute of Chemistry University of the Philippines Diliman Quezon City Philippines 1101, Dacanay, Francoise Neil; Institute of Chemistry University of the Philippines Diliman Quezon City Philippines 1101, Cheng, Ronny; Institute of Chemistry University of the Philippines Diliman Quezon City Philippines 1101   +4 more
core  

Real-world experience of brolucizumab in nAMD

Purpose: To evaluate real-world outcomes with neovascular age-related macular degeneration (nAMD) in relation to anatomical success, visual outcomes, and safety of intravitreal brolucizumab (IVBr) injection at 1.5 years. Methods: Prospective, randomized,
Anju Bansal, Dhananjay Raje, Prashant K Bawankule, Shilpi H Narnaware   +3 more
core   +1 more source

Automatic detection and prediction of nAMD activity change in retinal OCT using Siamese networks and Wasserstein Distance for ordinality [PDF]

Neovascular age-related macular degeneration (nAMD) is a leading cause of vision loss among older adults, where disease activity detection and progression prediction are critical for nAMD management in terms of timely drug administration and improving ...
Oghbaie, Marzieh, Aresta, Guilherme, Lachinov, Dmitrii, Bogunović, Hrvoje, Emre, Taha, Araújo, Teresa   +5 more
core   +1 more source

From Trials to Treatment: Current Evidence Supporting Faricimab Use in nAMD and DME. [PDF]

J Clin Med
Ruiz-Moreno JM, Bernal-Morales C, Esteban-Floría O, Rodríguez-de-la-Rúa E, Remolí-Sargues L, Borras-Blasco J, Gómez-Benlloch A, Cilveti E, Valsero-Franco S, Arriola-Naharro C, García-Lunar P, Kaminski-Santamaría S, Muñoz-Molina B, García-Layana A.   +13 more
europepmc   +1 more source

Long-term visual outcomes and development of retinal pigment epithelial and outer retinal atrophy in neovascular age-related macular degeneration: a comparison of conventional and novel classifications. [PDF]

BMC Ophthalmol
Hazra D, Tomita Y, Uchida A, Kato S, Nagai N, Suzuki M, Minami S, Kunimi H, Ban N, Kurihara T, Shinoda H, Ozawa Y, Negishi K.   +12 more
europepmc   +1 more source

Aqueous Humor Proteomics Reveals the Molecular Basis for Differential Treatment Responses in nAMD and pmCNV. [PDF]

Invest Ophthalmol Vis Sci
Zhao H, Gao B, Ding N, Zhang R, Zhou W, Song G, Li H, Wu H, Yang Y, Shao L, Dong L, Wei W.   +11 more
europepmc   +1 more source